Project Grant R44MH142152
- This $657,907 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The project aims to conduct a multi-level, longitudinal analysis examining the impact of expanding pharmacists' scope of practice on increasing uptake and retention of pre-exposure prophylaxis (PrEP) for HIV prevention. The research will utilize staggered difference-in-differences and agent-based...
- This Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) provides $731,738 to George Washington University to conduct a pilot feasibility study on integrating pre-exposure prophylaxis (PrEP) into emergency departments using decision support tools. The project aims to develop, validate, and pilot test a patient-centered decision support tool to promote PrEP persistence among high-risk populations after emergency or urgent care visits. The...
- This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, totaling $191,117, will fund the development and pilot of an anti-stigma intervention to improve communications between U.S. pharmacy staff and people seeking pre-exposure prophylaxis (PrEP) for HIV prevention. The key products and services to be delivered include: Qualitative assessments of the experiences and preferences of pharmacists, pharmacy...
- This Project Grant award, valued at $1,066,077.00 and provided by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research), will evaluate the "PREP & Soccer" multi-component implementation strategy delivered through CVS Health pharmacy locations in Miami-Dade, Florida. The goal is to increase PrEP (pre-exposure prophylaxis) knowledge and initial PrEP appointment attendance among PrEP-eligible men in a high-HIV priority...
- The National Institutes of Health (NIH) awarded a $250,000 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Fred Hutchinson Cancer Center in Seattle, Washington. The grant funds a hybrid effectiveness-implementation cluster-randomized controlled trial at 20 pharmacies in Kenya to evaluate whether introducing a remote nurse to assist with pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) delivery can improve clinical and implementation outcomes...
- The federal Project Grant award of $193,754 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports the development of an implementation strategy for pre-exposure prophylaxis (PrEP) based on academic detailing to improve PrEP prescribing and persistence among adolescents and young adults in pediatric primary care settings. The project, titled "ACADEMIC DETAILING TO OPTIMIZE PREP IMPLEMENTATION IN PEDIATRIC PRIMARY CARE...
- This $691,620 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to develop a web-based intervention to promote pre-exposure prophylaxis (PrEP) awareness and demand among women in the Southeastern United States. The project involves three key components: Developing a social media targeting approach to engage women with indications of PrEP need. This will include focus group discussions and a social media...
- The University of Pennsylvania was awarded a $744,279 federal Project Grant from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program. The grant, titled "Streamlining Telehealth for Expanded PrEP Utilization through Community Partnerships (STEP-UP)", aims to develop and evaluate an innovative model that positions community-based organizations as hubs for providing access to pre-exposure prophylaxis (PrEP) through telehealth....
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $962,973 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Duke University for the "Pharmacists for Prevention (P4P): Harnessing the Role of Pharmacists in Ending the HIV Epidemic Through Collaboration with Pharmacy Schools" project. The project aims to develop and implement a comprehensive curriculum to train pharmacy students in the South on HIV prevention, including...
- The National Institute of Mental Health (NIMH) awarded a $790,198 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to the University of Alabama at Birmingham (UAB). The grant, titled "PROTECT AL: PREP Optimization Through Enhanced Continuum Tracking," aims to develop effective interventions to scale up and sustain HIV pre-exposure prophylaxis (PrEP) utilization in the Southern United States, where HIV disproportionately affects the population. The key...
This Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) provides $242,827 to Empowerx, Inc. to develop and assess the "PEP/PREP via Pharmacist-Prescribing Implementation (PEPPI)" software. The project aims to support the implementation of effective and sustainable pharmacist-prescribed post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) services to improve access and adherence to these highly effective HIV prevention therapies. The project will partner with community organizations to follow a user-centered design process, develop a prototype of the PEPPI software, and then assess its impact on implementing pharmacist-prescribed PEP/PrEP services in real-world community pharmacy settings. The award period runs from September 22, 2025 through August 31, 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $242.8k | 9/22/25 |